Transdel Pharmaceuticals, Inc. (HROW)

Last Three Months

29-Jun-23 -- 28-Sep-23

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Buy

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

17

0

4

+1

0

+2

0

+3

Two Year Chart

29-Sep-21 -- 28-Sep-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Aug-23 7:30 AM View:	14-Aug-23 Purchase $98.89K	Baum Mark L Chief Executive Officer Director		Transdel Pharmaceuticals, Inc. - HROW	30% 1.55M to 2.02M	0	0	--	--	Show Txns Hide Txns

20-Jul-23 7:43 PM View:	18-Jul-23 Payment of Exercise ($2.49M)	Boll Andrew Chief Financial Officer		Transdel Pharmaceuticals, Inc. - HROW	65% 324.02K to 534.17K	0	0	--	--	Show Txns Hide Txns

20-Sep-23 6:39 PM View:	20-Sep-23 Purchase $86.71K	Opaleye Management Inc. 10% Owner		Transdel Pharmaceuticals, Inc. - HROW	1% 3.6M to 3.62M	0	0	--	--	Show Txns Hide Txns

15-Aug-23 7:30 AM View:	14-Aug-23 Purchase $338.40K	Makary Martin A. Director		Transdel Pharmaceuticals, Inc. - HROW	80% 25.0K to 45.0K	0	0	--	--	Show Txns Hide Txns

20-Jul-23 7:46 PM View:	18-Jul-23 Payment of Exercise ($1.99M)	Saharek John P. Chief Commercial Officer		Transdel Pharmaceuticals, Inc. - HROW	311% 54.08K to 222.2K	0	0	--	--	Show Txns Hide Txns